This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects:

Pharmacology Low‑importance This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles Low This article has been rated as Low-importance on the project's importance scale. Chemicals Low‑importance This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals articles Low This article has been rated as Low-importance on the project's importance scale.

Now that the term "methylphenylpiracetam" has actually been observed scientifically [1] ( pdf), I think it makes more sense to reorganize and move this article into a more general methylphenylpiracetam article. Bear in mind that all four enantiomers show sigma receptor activity. The E1R enantiomer can of course be given a bit more focus within it. It seems silly to have an article about an enantiomer alone. -- IO Device ( talk) 06:36, 12 October 2015 (UTC) reply

That sounds reasonable to me. Erik.Bjareholt ( talk) 09:53, 12 October 2015 (UTC) reply

Methylphenylpiracetam appears to be an appropriate name for the chemical compound and an appropriate title for the article. ChemNerd ( talk) 15:27, 13 October 2015 (UTC) reply

This is done. -- IO Device ( talk) 05:37, 1 January 2016 (UTC) reply